drugset / Trial / NCT05868993

Optimal Effective Local Anesthetic Volume for Pain Relief Using Brachial Plexus Block

NCT05868993 ↗

Phase 4 Unknown 150 enrolled Benaroya Research Institute
Non-randomizedParallel-groupTriple-blindTreatment

Summary

Prospective, patient-blinded study utilizing a novel Continuous Reassessment Method that concomitantly considers both block success and block side effects (lung dysfunction) for brachial plexus nerve blocks.

Timeline

Start
2023-02-17
Primary completion
2025-02
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 5 ml —

Indications

No indication recorded.